Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Neuroscience ; 152(3): 849-57, 2008 Mar 27.
Article in English | MEDLINE | ID: mdl-18308473

ABSTRACT

It is well known that noradrenergic locus coeruleus neurons decrease their activity during slow wave sleep and are quiescent during paradoxical sleep. It was recently proposed that their inactivation during paradoxical sleep is due to a tonic GABAergic inhibition arising from neurons located into the dorsal paragigantocellular reticular nucleus (DPGi). However, the discharge profile of DPGi neurons across the sleep-waking cycle as well as their connections with brain areas involved in paradoxical sleep regulation remain to be described. Here we show, for the first time in the unanesthetized rat that the DPGi contained a subtype of neurons with a tonic and sustained firing activation specifically during paradoxical sleep (PS-on neurons). Noteworthy, their firing rate increase anticipated for few seconds the beginning of the paradoxical sleep bout. By using anterograde tract-tracing, we further showed that the DPGi, in addition to locus coeruleus, directly projected to other areas containing wake-promoting neurons such as the serotonergic neurons of the dorsal raphe nucleus and hypocretinergic neurons of the posterior hypothalamus. Finally, the DPGi sent efferents to the ventrolateral part of the periaqueductal gray matter known to contain paradoxical sleep-suppressing neurons. Taken together, our original results suggest that the PS-on neurons of the DPGi may have their major role in simultaneous inhibitory control over the wake-promoting neurons and the permissive ventrolateral part of the periaqueductal gray matter as a means of influencing vigilance states and especially PS generation.


Subject(s)
Medulla Oblongata/cytology , Medulla Oblongata/physiology , Reticular Formation/cytology , Reticular Formation/physiology , Sleep, REM/physiology , Wakefulness/physiology , Action Potentials/physiology , Animals , Axonal Transport/physiology , Axons/physiology , Axons/ultrastructure , Brain Stem/cytology , Brain Stem/physiology , Cholera Toxin , Electrophysiology , Hypothalamus/cytology , Hypothalamus/physiology , Male , Neural Inhibition/physiology , Neural Pathways/cytology , Neural Pathways/physiology , Neurons/cytology , Neurons/physiology , Phytohemagglutinins , Rats , Rats, Sprague-Dawley , Staining and Labeling , Stilbamidines
2.
J Neurosci ; 20(11): 4217-25, 2000 Jun 01.
Article in English | MEDLINE | ID: mdl-10818157

ABSTRACT

Extracellular electrophysiological recordings in freely moving cats have shown that serotonergic neurons from the dorsal raphe nucleus (DRN) fire tonically during wakefulness, decrease their activity during slow wave sleep (SWS), and are nearly quiescent during paradoxical sleep (PS). The mechanisms at the origin of the modulation of activity of these neurons are still unknown. Here, we show in the unanesthetized rat that the iontophoretic application of the GABA(A) antagonist bicuculline on dorsal raphe serotonergic neurons induces a tonic discharge during SWS and PS and an increase of discharge rate during quiet waking. These data strongly suggest that an increase of a GABAergic inhibitory tone present during wakefulness is responsible for the decrease of activity of the dorsal raphe serotonergic cells during slow wave and paradoxical sleep. In addition, by combining retrograde tracing with cholera toxin B subunit and glutamic acid decarboxylase immunohistochemistry, we demonstrate that the GABAergic innervation of the dorsal raphe nucleus arises from multiple distant sources and not only from interneurons as classically accepted. Among these afferents, GABAergic neurons located in the lateral preoptic area and the pontine ventral periaqueductal gray including the DRN itself could be responsible for the reduction of activity of the serotonergic neurons of the dorsal raphe nucleus during slow wave and paradoxical sleep, respectively.


Subject(s)
Neurons/physiology , Raphe Nuclei/cytology , Raphe Nuclei/physiology , Serotonin/physiology , gamma-Aminobutyric Acid/physiology , Animals , Bicuculline , Cholera Toxin/pharmacology , Electroencephalography/drug effects , Electromyography/drug effects , Electrophysiology , GABA Antagonists , Glutamate Decarboxylase/metabolism , Immunohistochemistry , Iontophoresis , Male , Neurons/metabolism , Patch-Clamp Techniques , Raphe Nuclei/metabolism , Rats , Rats, Sprague-Dawley , Receptors, GABA-A/drug effects , Sleep/drug effects , Sleep/physiology , Sleep, REM/drug effects , Sleep, REM/physiology , gamma-Aminobutyric Acid/metabolism , gamma-Aminobutyric Acid/pharmacology
3.
Neuroreport ; 7(18): 3081-5, 1996 Nov 25.
Article in English | MEDLINE | ID: mdl-9116245

ABSTRACT

In order to determine the localization of the glycinergic neurones responsible for the hyperpolarization of the rat trigeminal motoneurones during paradoxical sleep, we developed a new double immunohistochemical method combining the b subunit of the cholera toxin (CTb), a very sensitive retrograde tracer, with glycine immunohistochemistry. After iontophoretic injections of CTb into the trigeminal motor nucleus (Mo5), a large number of double-labelled cells was observed bilaterally in the parvocellular reticular nucleus alpha, dorsolateral to the descending branch of the facial nerve. A moderate number of double-labelled neurones was found in the ipsilateral parvocellular reticular nucleus at the level of the facial nucleus, and bilaterally in the raphe magnus and the gigantocellular reticular alpha nuclei. These results suggest that the glycinergic neurones hyperpolarizing the trigeminal motoneurons during paradoxical sleep might be localized in the parvocellular reticular nucleus alpha.


Subject(s)
Glycine/physiology , Motor Neurons/physiology , Trigeminal Nuclei/physiology , Animals , Cholera Toxin , Immunohistochemistry , Iontophoresis , Male , Rats , Rats, Sprague-Dawley , Trigeminal Nuclei/anatomy & histology
4.
Neuroreport ; 8(1): 351-5, 1996 Dec 20.
Article in English | MEDLINE | ID: mdl-9051809

ABSTRACT

The noradrenergic neurones of the locus coeruleus (LC) discharge tonically during wakefulness, decrease their activity during slow wave sleep and are virtually quiescent during paradoxical sleep. We recently demonstrated an inhibitory glycinergic input to the locus coeruleus and proposed that this could be responsible for inhibition of the LC during paradoxical sleep. To test this proposal, we developed a method combining polygraphic recordings, iontophoresis and single-unit extracellular recordings in the unanaesthetized head-restrained rat. Iontophoretically applied strychnine, a specific glycine antagonist, induced strong excitation of LC neurones during paradoxical sleep, but also during slow wave sleep and wakefulness. These results suggest that glycine tonically inhibits noradrenergic LC neurones throughout the entire sleep-waking cycle and not only during paradoxical sleep.


Subject(s)
Glycine Agents/pharmacology , Locus Coeruleus/cytology , Neurons/drug effects , Sleep/physiology , Strychnine/pharmacology , Wakefulness/physiology , Anesthesia , Animals , Electroencephalography , Electromyography , Electrophysiology , Iontophoresis , Locus Coeruleus/drug effects , Polysomnography , Rats , Rats, Sprague-Dawley , Restraint, Physical
5.
Pharmacol Biochem Behav ; 73(3): 557-63, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12151030

ABSTRACT

A number of studies in humans and various other species have shown that chronic treatment with antidepressants, such as tricyclics or selective serotonin reuptake inhibitors (SSRIs), induces a decrease or suppression of rapid eye movement (REM) sleep. The effect of a new selective serotonin and noradrenaline reuptake inhibiting (SNRI) antidepressant, milnacipran, on REM sleep has been investigated and compared with that of the SSRI, paroxetine, and the tricyclic, imipramine. Rats injected with vehicle or milnacipran twice a day showed, over 24 h, a similar amount of REM sleep, number and duration of REM sleep episodes to control rats. In contrast, rats treated acutely with imipramine or paroxetine showed a statistically significant decrease in the total quantity of REM sleep. The number of REM sleep episodes was decreased while their duration was increased. A more detailed analysis showed further that the quantity of REM sleep was decreased for the first 4 h following the 9 a.m. injection but not the 7 p.m. injection for milnacipran, during the first 6 h for paroxetine and for the entire light-dark period for imipramine. For all drugs, the quantities of slow-wave sleep and waking over 24 h were not significantly different from control conditions and no rebound of REM sleep occurred during the day following withdrawal. Power spectrum analysis revealed no global changes in the different electroencephalogram (EEG) waves (delta, theta, gamma) between the control condition and the different treatments during waking, slow-wave sleep or REM sleep. Taken together our results indicate that the SNRI, milnacipran, at therapeutic doses, induces only minor disturbances of REM sleep compared with a SSRI and tricyclic antidepressant used. Possible mechanisms responsible for the difference of action on REM sleep of milnacipran are discussed.


Subject(s)
Adrenergic Uptake Inhibitors/pharmacology , Antidepressive Agents, Second-Generation/pharmacology , Antidepressive Agents, Tricyclic/pharmacology , Cyclopropanes/pharmacology , Imipramine/pharmacology , Paroxetine/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacology , Sleep Stages/drug effects , Animals , Behavior, Animal/drug effects , Body Weight/drug effects , Male , Milnacipran , Rats , Sleep/drug effects , Sleep, REM/drug effects , Wakefulness/drug effects
6.
Arch Ital Biol ; 142(4): 397-411, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15493544

ABSTRACT

This paper is dedicated to our mentor, Michel Jouvet who inspired our career and transmitted to us his passion for the study of the mechanisms responsible for paradoxical sleep genesis and also that of its still mysterious functions. We expose in the following the progresses in the knowledge in this field brought during 40 years by Michel Jouvet and his team and more recently by the members of a new CNRS laboratory in which we aim to pursue in the path opened by Michel Jouvet.


Subject(s)
Brain Stem/physiology , Neural Pathways/physiology , Neurotransmitter Agents/physiology , Sleep, REM/physiology , Animals , Brain Stem/anatomy & histology , Humans , Models, Neurological , Neural Inhibition/physiology , Neural Pathways/anatomy & histology , Rats , Reticular Formation/anatomy & histology , Reticular Formation/physiology
7.
Neuropharmacology ; 85: 349-56, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24796256

ABSTRACT

Histamine receptor type 3 (H3) antagonists are promising awakening drugs for treatment of sleep disorders. However, few works have tried to identify their cognitive effects after sleep restriction and their impact on associated neural networks. To that aim, Bl/6J male mice were submitted to acute sleep restriction in a shaker apparatus that prevents sleep by transient (20-40 ms) up and down movements. Number of stimulations (2-4), and delay between 2 stimulations (100-200 ms) were randomized. Each sequence of stimulation was also randomly administered (10-30 s interval) for 20 consecutive hours during light (8 h) and dark (12 h) phases. Immediately after 20 h-sleep restriction, mice were injected with H3 antagonist (ciproxifan 3 mg/kg ip) and submitted 30-min later to a working memory (WM) task using spatial spontaneous alternation behaviour. After behavioural testing, brains were perfused for Fos immunohistochemistry to assess neuronal brain activation in the dorsal dentate gyrus (dDG) and the prefrontal cortex. Results showed that sleep restriction decreased slow wave sleep (from 35.8±1.4% to 9.2±2.7%, p<0.001) and was followed by sleep rebound (58.2±5.9%, p<0.05). Sleep restriction did not modify anxiety-like reactivity and significantly decreased WM at long (30 s) but not short (5 s) inter-trial intervals. Whereas sleep restriction failed to significantly modify immunopositive cells in vehicles, ciproxifan administration prevented WM deficits in sleep restricted mice through significant increases of Fos labelling in prelimbic, infralimbic and cingulate 2 cortex. In conclusion, ciproxifan at 3 mg/kg enhanced WM in sleep restricted mice through specific modulation of prefrontal cortex areas.


Subject(s)
Imidazoles/pharmacology , Memory, Short-Term/drug effects , Nootropic Agents/pharmacology , Prefrontal Cortex/drug effects , Sleep Deprivation/drug therapy , Animals , Anxiety/physiopathology , Hippocampus/drug effects , Hippocampus/physiopathology , Histamine H3 Antagonists/pharmacology , Immunohistochemistry , Male , Memory, Short-Term/physiology , Mice, Inbred C57BL , Neuropsychological Tests , Physical Stimulation , Polysomnography , Prefrontal Cortex/physiopathology , Proto-Oncogene Proteins c-fos/metabolism , Sleep/drug effects , Sleep/physiology , Sleep Deprivation/physiopathology , Time Factors
8.
Sleep Res Online ; 1(3): 102-8, 1998.
Article in English | MEDLINE | ID: mdl-11382865

ABSTRACT

The present study was aimed to compare in detail the distribution within the rostral ventromedial medulla of Methionin-Enkephalin-immunoreactive neurons with efferent projections to the facial or trigeminal motor nuclei, using a double immunostaining technique in colchicine-treated cats. Following cholera toxin B subunit injections in the facial or trigeminal motor nuclei, we found that respectively 55% and 65% of the medium to large-sized retrogradely labeled cells in the lateral part of the nucleus reticularis magnocellularis were Methionin-Enkephalin-positive. For both motor nuclei, the double-labeled neurons had similar morphology and size and were located exactly in the same area. They could therefore belong to the same population of reticular enkephalinergic neurons. Based on these and previous anatomical and electrophysiological data, we propose that these enkephalin-containing neurons could participate in the hyperpolarization of brainstem and spinal somatic motoneurons during paradoxical sleep.


Subject(s)
Facial Muscles/innervation , Medulla Oblongata/anatomy & histology , Medulla Oblongata/physiology , Muscle Tonus/physiology , Sleep, REM/physiology , Animals , Cats , Enkephalins/metabolism , Female , Immunohistochemistry , Male , Methionine/metabolism , Neural Pathways/anatomy & histology , Neurons/metabolism , Reticular Formation/cytology
9.
Eur J Neurosci ; 11(3): 1058-66, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10103098

ABSTRACT

The amino acid glycine is a major inhibitory neurotransmitter in the brainstem and is likely involved in the tonic inhibition of the monoaminergic neurons during all sleep-waking stages. In order to determine the neurons at the origin of the glycinergic innervation of the two principal monoaminergic nuclei, the locus coeruleus and the dorsal raphe of the rat, we applied a double-labelling technique, combining retrograde transport of cholera-toxin B subunit with glycine immunohistochemistry. Using this technique, we found that the locus coeruleus and dorsal raphe nuclei receive a common glycinergic innervation from the ventral and ventrolateral periaqueductal grey, including the adjacent deep mesencephalic reticular nucleus. Small additional glycinergic inputs to these nuclei originated from the lateral paragigantocellular nucleus and the rostral ventromedial medullary reticular formation. The potential role of these glycinergic inputs in the control of the excitability of the monoaminergic neurons of the locus coeruleus and dorsal raphe nuclei is discussed.


Subject(s)
Glycine/analysis , Locus Coeruleus/chemistry , Locus Coeruleus/cytology , Raphe Nuclei/chemistry , Raphe Nuclei/cytology , Animals , Antibody Specificity , Cholera Toxin , Glycine/immunology , Immunohistochemistry , Male , Neural Inhibition/physiology , Neural Pathways , Norepinephrine/analysis , Norepinephrine/physiology , Periaqueductal Gray/chemistry , Periaqueductal Gray/cytology , Rats , Rats, Sprague-Dawley , Reticular Formation/chemistry , Reticular Formation/cytology , Serotonin/analysis , Serotonin/physiology , Sleep, REM/physiology
10.
Eur J Neurosci ; 10(3): 964-70, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9753163

ABSTRACT

It is well known that noradrenergic locus coeruleus (LC) neurons decrease their activity during slow wave sleep (SWS) and are virtually quiescent during paradoxical sleep (PS). It has been proposed that a GABAergic input could be directly responsible for this sleep-dependent neuronal inactivation. To test this hypothesis, we used a new method combining polygraphic recordings, microiontophoresis and single-unit extracellular recordings in unanaesthetized head-restrained rats. We found that iontophoretic application of bicuculline, a specific GABA(A)-receptor antagonist, during PS and SWS restore a tonic firing in the LC noradrenergic neurons. We further observed that the application of bicuculline during wakefulness (W) induced an increase of the discharge rate. Of particular importance for the interpretation of these results, using the microdialysis technique, Nitz and Siegel (Neuroscience, 1997; 78: 795) recently found an increase of the GABA release in the cat LC during SWS and PS as compared with waking values. Based on these and our results, we therefore propose that during W, the LC cells are under a GABAergic inhibitory tone which progressively increases at the entrance and during SWS and PS and is responsible for the inactivation of these neurons during these states.


Subject(s)
Locus Coeruleus/physiology , Neurons/physiology , Norepinephrine/physiology , Sleep/physiology , gamma-Aminobutyric Acid/pharmacology , Animals , Bicuculline/administration & dosage , Bicuculline/pharmacology , Electrophysiology , GABA Antagonists/administration & dosage , GABA Antagonists/pharmacology , Iontophoresis , Locus Coeruleus/cytology , Locus Coeruleus/drug effects , Male , Neurons/drug effects , Polysomnography/drug effects , Rats , Rats, Sprague-Dawley , Restraint, Physical , Wakefulness/drug effects
11.
J Sleep Res ; 9(1): 89-96, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10733694

ABSTRACT

Modafinil is a newly discovered waking substance now being used in the treatment of hypersomnia and narcolepsy. We have shown previously in the cat that, unlike amphetamine, modafinil induces long-lasting wakefulness (W) without behavioral excitation and subsequent sleep rebound, and that its waking effect does not depend on endogenous catecholamines. To further characterize the awakening properties of modafinil and current psychostimulants in experimental models of hypersomnia, we examined the effect of oral administration of placebo, modafinil (5 mg kg-1) or amphetamine (1 mg kg-1) on the sleep/wake cycle and power spectral density (PSD) in cats after an 18-h water-tank sleep deprivation period. We found that the placebo had no effect on the dynamics of sleep recovery, while both modafinil and amphetamine induced suppression of cortical slow activity and a waking state lasting 6-8 h. After the amphetamine-induced waking period, both deep slow wave sleep (SWS2) and paradoxical sleep (PS) occurred in greater amounts than after placebo and the PSD during SWS was also increased. Thus, the cumulative time spent in W during a 48-h period was similar to that with placebo, indicating enhanced sleep rebound. In contrast, after the modafinil-induced W, the occurrence and evolution of SWS2 or PS, as well as the PSD during SWS, were similar to those seen with placebo during the same period, so that the total time spent in W in a 48-h period remained significantly higher than the control level, indicating no additional sleep rebound. These results indicate that modafinil is effective against somnolence and hypersomnia and does not produce a subsequent increase in sleep and suggest that the pharmacological profile of modafinil is different from that of amphetamine.


Subject(s)
Amphetamine/pharmacology , Amphetamine/therapeutic use , Benzhydryl Compounds/pharmacology , Benzhydryl Compounds/therapeutic use , Central Nervous System Stimulants/pharmacology , Central Nervous System Stimulants/therapeutic use , Disorders of Excessive Somnolence/drug therapy , Disorders of Excessive Somnolence/etiology , Sleep Deprivation/complications , Sleep, REM/physiology , Wakefulness/physiology , Animals , Cats , Electroencephalography , Electromyography , Electrooculography , Modafinil , Time Factors
12.
Eur J Neurosci ; 12(9): 3361-74, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10998119

ABSTRACT

The pallido-subthalamic pathway powerfully controls the output of the basal ganglia circuitry and has been implicated in movement disorders observed in Parkinson's disease (PD). To investigate the normal functioning of this pathway across the sleep-wake cycle, single-unit activities of subthalamic nucleus (STN) and globus pallidus (GP) neurons were examined, together with cortical electroencephalogram and nuchal muscular activity, in non-anaesthetized head-restrained rats. STN neurons shifted from a random discharge in wakefulness (W) to a bursting pattern in slow wave sleep (SWS), without any change in their mean firing rate. This burst discharge occurred in the 1-2 Hz range, but was not correlated with cortical slow wave activity. In contrast, GP neurons, with a mean firing rate higher in W than in SWS, exhibited a relatively regular discharge whatever the state of vigilance. During paradoxical sleep, both STN and GP neurons increased markedly their mean firing rate relative to W and SWS. Our results are not in agreement with the classical 'direct/indirect' model of the basal ganglia organization, as an inverse relationship between STN and GP activities is not observed under normal physiological conditions. Actually, because the STN discharge pattern appears dependent on coincident cortical activity, this nucleus can hardly be viewed as a relay along the indirect pathway, but might rather be considered as an input stage conveying corticothalamic information to the basal ganglia.


Subject(s)
Arousal/physiology , Globus Pallidus/cytology , Globus Pallidus/physiology , Subthalamic Nucleus/cytology , Subthalamic Nucleus/physiology , Animals , Circadian Rhythm/physiology , Conditioning, Psychological/physiology , Electroencephalography , Electromyography , Male , Neurons/physiology , Rats , Rats, Sprague-Dawley , Restraint, Physical/instrumentation , Sleep/physiology , Sleep, REM/physiology , Wakefulness/physiology
13.
J Neurosci Res ; 61(1): 88-100, 2000 Jul 01.
Article in English | MEDLINE | ID: mdl-10861804

ABSTRACT

In order to avoid any artifactual pharmacological interferences with anaesthetic agents, a procedure has been developed for working on the awake, anaesthetic-free rat in a head-restrained condition. It allows, on the same animal and over several consecutive days, single-unit recordings in combination with systemic or local pharmacology (microiontophoresis or micropressure ejections), as well as monitoring vigilance states via the electroencephalogram and the electromyogram. After the cementing of a special "U"-shaped device on its skull under general anaesthesia, the animal is progressively habituated to stay daily, for several hours, under a painless corresponding stereotaxic restraint. This system can be easily adapted to different stereotaxic frames and, because of its spatial flexibility for targetting the desired rostrocaudal or lateral positions, allows access to a large number of cerebral structures. Experiments performed on Globus Pallidus, Substantia Nigra, and Locus Coeruleus neurons, combining the different possibilities of this system, are reported. They demonstrate, on the awake anaesthetic-free head-restrained rat, and under suitable ethical conditions, the feasibility of single-unit recordings of identified neurons associated with the study of their pharmacological reactivity after systemic or local drug administrations without any other drug interferences, and in physiologically relevant conditions such as the spontaneous alternance of vigilance states.


Subject(s)
Arousal/physiology , Electroencephalography/methods , Electromyography/instrumentation , Stereotaxic Techniques , Action Potentials/drug effects , Action Potentials/physiology , Anesthesia , Animals , Conditioning, Psychological , Electroencephalography/instrumentation , Electromyography/methods , Habituation, Psychophysiologic , Iontophoresis , Locus Coeruleus/physiology , Male , Rats , Rats, Sprague-Dawley , Restraint, Physical/instrumentation , Substantia Nigra/physiology , gamma-Aminobutyric Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL